HealthcareUS

Editas Medicine Layoffs

January 2023

Editas Medicine announced a layoff affecting 0 employees (20% of its workforce) in January 2023. The company operates in the Healthcare sector.

Share:
People Affected

0

Percentage

20%

Announced Date

Jan 9, 2023

Company Information

Industry
Healthcare
Country
US
Region
Boston
Last Updated: Apr 18, 2026

About

Editas Medicine, an early gene-editing biotech company, laid off 20% of its workforce in January 2023 as part of a strategic restructuring to streamline its pipeline and operations. The layoffs coincided with the departure of its Chief Scientific Officer and were announced ahead of the J.P. Morgan Healthcare Conference. The company, which has faced challenges in advancing its clinical programs, made these cuts to prioritize key research and development efforts and extend its financial runway in a difficult market for the biotechnology industry.

Report an Error

If you find incorrect information, please let us know so we can correct it.

support@layoffs.nl